MedTrace Logo

Potential Diagnostic Biomarkers for Aortic Dissection in the Emergency Department

NCT06065306 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2024-04-16

No results posted yet for this study

Summary

The goal of this observational study is to determine the utility of desmosine, D-dimer and aggrecan as early diagnostic biomarkers in aortic dissection. The main questions it aims to answer are:

* To investigate the plasma levels of selected biomarkers in ED patients with confirmed aortic dissection
* To study the diagnostic performance of plasma levels of selected biomarkers for aortic dissection
* To study the association between plasma levels of selected biomarkers and clinical outcomes

Conditions

  • Aortic Dissection

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-18
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06065306 on ClinicalTrials.gov